Concepedia

Publication | Open Access

The role of comprehensive analysis with circulating tumor DNA in advanced non‐small cell lung cancer patients considered for osimertinib treatment

DOIFull Paper Access

11

Citations

26

References

2021

Year

Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, N Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda,
Cancer Medicine

Abstract

NGS of ctDNA could be a promising method for predicting osimertinib efficacy in patients with advanced NSCLC harboring EGFR T790 M.

References

YearCitations

Page 1